The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
Open accessAbstract
We recently described the isolation from human serum of a serum protein (C4 binding protein) that functions as an essential cofactor for C3b inactivator in the proteolysis of fluid-phase C4b and to a much lesser extent, C3b. We show here the role of C4 binding protein in the formation and function of the classical pathway C3 convertase (C42). C4 binding protein interferes with the assembly of the membrane-bound C3 convertase of the classical pathway and accelerates the decay of C42 in a dose-dependent fashion. Its removal from serum by means of specific immune absorption promotes the vigorous consumption of C3 after addition of C1; this effect is abolished by reconstitution with purified C4 binding protein. Although C4 binding protein inhibits the hemolytic function of cell-bound C4b, we did not detect any change in the structure of C4b even after prolonged incubations of EAC14 with C4 binding protein. For this reason, and on the basis of studies of the time required for maximal reactivity (Tmax) of cellular intermediates generated in the presence of C4 binding protein and limited amounts of C2, we conclude that the effects of C4 binding protein are probably mediated by displacing C2a from specific binding sites on C4b. In addition, C4 binding protein enhances the cleavage by C3b inactivator of the alpha' chain of cell-bound C4b. When EAC14 cells were incubated with both control proteins, the Tmax of the cells was prolonged and the lysis was markedly diminished. We conclude that C4 binding protein and C3b inactivator control the C3 convertase of the classical pathway in a fashion similar to that described for beta 1H and C3b inactivator in the alternative pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Modulation of the alternative complement pathways by beta 1 H globulin.
Whaley, K., & Ruddy, S. (1976) · The Journal of experimental medicine · doi:10.1084/jem.144.5.1147 · Cited by 583
Control of the amplification convertase of complement by the plasma protein beta1H.
Weiler, J. M., Daha, M. R., Austen, K. F., & Fearon, D. T. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3268 · Cited by 570
CHROMATOGRAPHIC RESOLUTION OF THE FIRST COMPONENT OF HUMAN COMPLEMENT INTO THREE ACTIVITIES
Lepow, I. H., Naff, G. B., Todd, E. W., Pensky, J., & Hinz, C. F. (1963) · The Journal of Experimental Medicine · doi:10.1084/jem.117.6.983 · Cited by 378
Activation of the alternative complement pathway due to resistance of zymosan-bound.
Fearon, D. T., & Austen, K. F. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.4.1683 · Cited by 284
Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator.
Fujita, T., Gigli, I., & Nussenzweig, V (1978) · The Journal of experimental medicine · doi:10.1084/jem.148.4.1044 · Cited by 284
Self-citationHuman C4-binding protein. I. Isolation and characterization
Scharfstein, J., Ferreira, A., Gigli, I., & Nussenzweig, V (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.148.1.207 · Cited by 258
Self-citationThe unactivated form of the first component of human complement, C1
Gigli, I., Porter, R. R., & Sim, R. B. (1976) · Biochemical Journal · doi:10.1042/bj1570541 · Cited by 190
Self-citation
Cited by
Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C., Carson, G. R., Concino, M. F., Boyle, M. P., Roux, K. H., Weisfeldt, M. L., & Fearon, D. T. (1990) · Science · doi:10.1126/science.2371562 · Cited by 977
Manfioletti, G., Brancolini, C., Avanzi, G., & Schneider, C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4976 · Cited by 586
Medof, M. E., Kinoshita, T., & Nussenzweig, V (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1558 · Cited by 561
Self-citationControl of the Complement System
Uszewski, M. K., Farries, T. C., Lublin, D. M., Rooney, I. A., & Atkinson, J. P. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60868-8 · Cited by 500
Fraga, T. R., Carvalho, E., Isaac, L., & Barbosa, A. S. (2015) · Molecular Medical Microbiology · doi:10.1016/b978-0-12-397169-2.00107-4 · Cited by 453
Dahlbäck, B. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646373 · Cited by 349
Antagonism of the complement component C4 by flavivirus nonstructural protein NS1
Avirutnan, P., Fuchs, A., Hauhart, R. E., Somnuke, P., Youn, S., Diamond, M. S., & Atkinson, J. P. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092545 · Cited by 347
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
DeCordova, S., Shastri, A., Tsolaki, A. G., Yasmin, H., Klein, L., Singh, S. K., & Kishore, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01402 · Cited by 346
Inhibition of the Complement Cascade by the Major Secretory Protein of Vaccinia Virus
Kotwal, G. J., Isaacs, S. N., McKenzie, R., Frank, M. M., & Moss, B. (1990) · Science · doi:10.1126/science.2237434 · Cited by 321
Membrane Complement Receptors Specific for Bound Fragments of C3
Ross, G. D., & Medof, M. E. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60341-7 · Cited by 308
The alternative pathway of complement
Pangburn, M. K., & Müller-Eberhard, H. J. (1984) · Springer Seminars in Immunopathology · doi:10.1007/bf01893019 · Cited by 291
Ram, S., McQuillen, D. P., Gulati, S., Elkins, C., Pangburn, M. K., & Rice, P. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.4.671 · Cited by 278
Complement receptor is an inhibitor of the complement cascade.
Iida, K., & Nussenzweig, V (1981) · The Journal of experimental medicine · doi:10.1084/jem.153.5.1138 · Cited by 264
Self-citationComplement in removal of the dead – balancing inflammation
Martin, M., & Blom, A. M. (2016) · Immunological Reviews · doi:10.1111/imr.12462 · Cited by 130
Tsiftsoglou, S. A., Arnold, J. N., Roversi, P., Crispin, M. D., Radcliffe, C., Lea, S. M., Dwek, R. A., Rudd, P. M., & Sim, R. B. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.09.007 · Cited by 29
Metadata
- Authors
- Gigli, I., Fujita, T., & Nussenzweig, V
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1979-12
- Volume
- 76
- Issue
- 12
- Pages
- 6596-6600
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1985261073
- Cited by
- 338
- References
- 19
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.